novel
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
discov
detect
antigen
antibodi
sarscov
human
specimen
suspect
sar
play
import
role
prevent
infect
develop
novel
rapid
immunochromatograph
test
rict
base
sandwich
format
enzym
immunoassay
eia
allinon
devic
detect
nativ
nucleocapsid
antigen
nag
sarscov
use
monoclon
antibodi
moab
produc
immun
recombin
nag
mice
rict
qualit
assay
respiratori
aspir
serum
specimen
assay
posit
result
judg
subject
appear
blue
line
devic
min
sampl
appli
rict
sever
pair
moab
show
high
sensit
detect
recombin
nag
well
viral
nag
sarscov
best
moab
immobil
antibodi
enzym
label
respect
regard
analyt
sensit
rict
detect
nag
pgml
recombin
nag
tcid
ml
sarscov
specif
rict
human
sera
nasopharyng
aspir
nsp
use
rict
base
eia
use
pair
sensit
specif
reliabl
rapid
assay
detect
nag
sarscov
treat
either
heat
triton
sinc
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
first
discov
need
develop
sensit
simpl
assay
detect
antigen
antibodi
becom
increasingli
press
sarscov
detect
realtim
pcr
earli
phase
infect
techniqu
allow
highli
sensit
determin
use
nasopharyng
aspir
nsp
sar
patient
sensit
specif
respect
likewis
method
employ
enzymelink
immunosorb
assay
elisa
also
achiev
sensit
detect
use
blood
sar
patient
detect
antibodi
sarscov
elisa
western
blot
wb
patient
serum
also
report
simpl
devic
base
rapid
enzym
immunoassay
eia
format
detect
sarscov
antigen
could
use
pointofcar
test
near
patient
care
site
yet
develop
recent
immunochromatograph
test
use
colloid
gold
particl
serv
detector
recombin
nag
sarscov
sourc
antigen
captur
antibodi
describ
measur
antibodi
sarscov
note
howev
immunochromatograph
test
method
use
gold
particl
detector
like
less
sensit
detect
antigen
eia
elisa
amplifi
signal
intens
enzym
catalyz
substrat
thu
rapid
immunochromatograph
test
rict
method
base
eia
appear
promis
analyt
detect
high
sensit
principl
behind
rict
assay
method
follow
sampl
appli
onto
sampl
applic
pad
rict
devic
describ
fig
immun
complex
form
nag
appli
sampl
antinag
antibodi
conjug
alp
pad
immun
complex
elut
toward
detect
zone
later
flow
along
membran
due
capillari
forc
diffus
ruptur
develop
reservoir
bottom
devic
thereaft
nag
immun
complex
react
antinag
antibodi
immobil
detect
zone
alp
complex
catalyz
dephosphoryl
phosphat
disodium
salt
bcip
result
color
develop
visual
detect
zone
judg
posit
express
recombin
nag
sarscov
urbani
strain
base
genom
sequenc
develop
novel
rict
base
eia
measur
nag
sarscov
use
monoclon
antibodi
moab
produc
immun
recombin
nag
mice
moab
recombin
nag
prepar
mous
ascit
accord
convent
procedur
purifi
ascit
affin
chromatographi
protein
agaros
mapsii
kit
biorad
hercul
ca
prepar
synthet
peptid
gqtvtkksaaeaskkpr
amino
acid
sequenc
nag
term
peptid
use
immun
agent
instead
recombin
nag
polyclon
antibodi
use
captur
alkalin
phosphat
alp
rict
assay
prepar
rabbit
serum
immun
alp
immobil
r
posit
membran
rict
devic
chemic
use
list
chemic
use
reagentgrad
qualiti
molecular
weight
marker
kit
purchas
invitrogen
bench
mark
prestain
protein
ladder
invitrogen
japan
kk
tokyo
japan
construct
cdna
fragment
base
genom
sequenc
correspond
nag
sarscov
viru
urbani
strain
obtain
genbank
access
thirtytwo
differ
primer
length
base
synthes
base
sequenc
consecut
region
entir
sequenc
ie
primer
sequenc
overlap
neighbor
primer
sequenc
base
entir
nag
sequenc
cover
primer
synthes
sigma
genosi
japan
ishikari
hokkaido
japan
two
larg
cdna
fragment
bp
contain
nhei
restrict
site
posit
nag
prepar
stepwis
use
primer
span
base
respect
pcr
amplif
model
dna
synthes
appli
biosystem
foster
citi
ca
exampl
polynucleotid
span
base
synthes
follow
solut
contain
primer
span
base
mix
pcr
amplif
carri
presenc
pfu
dna
polymeras
describ
previous
result
format
oligonucleotid
span
base
method
use
addit
neighbor
primer
end
oligom
span
base
carri
use
consecut
primer
eventu
result
cdna
fragment
span
base
nag
final
fulllength
dna
polynucleotid
contain
ecori
bamhi
site
obtain
two
larg
dna
fragment
clear
ligat
site
appli
construct
plasmid
pcr
use
primer
ccgccgg
gtt
obtain
recombin
nag
dna
purifi
use
pcr
purif
kit
follow
manufactur
instruct
qiagen
hilden
germani
insert
ecori
bamhi
site
express
vector
result
plasmid
name
pwsn
escherichia
coli
strain
transform
pwsn
vector
describ
elsewher
growth
harvest
transform
e
coli
cell
subsequ
treatment
obtain
lysat
cell
perform
essenti
describ
previous
recombin
nag
protein
lysat
suspens
also
purifi
describ
previous
concentr
purifi
recombin
nag
determin
use
bca
protein
assay
reagent
pierc
biotechnolog
inc
rockford
il
sarscov
urbani
strain
provid
dr
koichi
morita
nagasaki
univers
prepar
biosafeti
level
laboratori
graduat
school
veterinari
medicin
hokkaido
univers
prepar
treatment
live
virus
carri
accord
guidelin
propos
hokkaido
univers
briefli
vero
cell
grown
confluenc
minimum
essenti
medium
contain
fetal
bovin
serum
cell
infect
sarscov
tcid
ml
cultur
hr
cultur
centrifug
rpm
min
supernat
collect
supernat
solut
heat
min
thereaft
kept
use
supernat
cultur
vero
cell
infect
sarscov
also
prepar
control
protein
express
e
coli
purifi
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
describ
previous
wb
electrophoret
transfer
protein
recombin
nag
nativ
nag
gel
nitrocellulos
paper
pore
mm
schleicher
schnell
germani
perform
essenti
describ
previous
brief
nitrocellulos
paper
follow
incub
either
moab
mous
peptid
serum
subsequ
antimous
antibodi
conjug
peroxidas
pod
dako
cytom
co
ltd
kyoto
japan
wash
phosphatebuff
salin
pb
buffer
contain
tween
solut
appli
paper
intens
color
catal
pod
detect
nativ
nag
use
wb
analysi
prepar
follow
precipit
obtain
ultracentrifug
supernat
cultur
vero
cell
sarscov
given
sd
mm
tri
buffer
ph
boil
min
appli
sdspage
mous
peptid
serum
fig
mous
moab
sarscov
fig
use
primari
antibodi
rabbit
antimous
antibodi
conjug
pod
use
secondari
antibodi
evalu
immunoreact
moab
elisa
well
plastic
micropl
falcon
micro
test
iii
flexibl
assay
plate
becton
dickinson
san
jose
ca
coat
mgml
recombin
nag
mm
pb
ph
hr
plate
wash
mm
pb
ph
contain
tween
elisa
carri
describ
previous
briefli
ml
solut
contain
moab
eight
differ
concentr
ngml
ad
well
plate
incub
hr
room
temperatur
wash
pb
buffer
contain
tween
goat
antimous
antibodi
conjug
pod
dako
cytom
co
ltd
kyoto
japan
ad
incub
hr
well
wash
pb
buffer
ml
acid
ammonium
salt
abt
h
ad
plate
incub
min
absorb
nm
measur
concentr
moab
maximum
absorb
use
index
appar
affin
antibodi
competit
elisa
assay
moab
well
plastic
micropl
coat
mgml
recombin
nag
essenti
elisa
procedur
describ
use
except
pod
use
label
enzym
assay
buffer
mm
tri
buffer
ph
contain
nacl
bsa
briefli
mixtur
mgml
moab
label
alp
mgml
free
moab
use
competitor
ad
well
micropl
incub
hr
room
temperatur
well
wash
pnpp
solut
ad
absorb
nm
measur
detect
recombin
nativ
nag
sarscov
twostep
sandwichformat
elisa
well
plastic
micropl
nuncimmunot
modul
plate
nunc
ac
roskild
denmark
coat
moab
recombin
nag
synthet
peptid
phosphat
buffer
ph
hr
coat
concentr
well
set
mgml
moab
wash
block
procedur
describ
previous
elisa
carri
twostep
sandwich
format
brief
moab
nag
sarscov
conjug
alp
use
label
ml
test
sampl
contain
recombin
nag
protein
obtain
supernat
cultur
vero
cell
sarscov
place
micropl
well
incub
hr
ambient
temperatur
plate
wash
mm
tri
buffer
ph
contain
nacl
triton
ml
moab
conjug
alp
ad
incub
hr
well
wash
ml
pnpp
solut
ad
absorb
nm
measur
detect
limit
valu
estim
standard
elisa
curv
signaltonois
ratio
snr
basic
concept
rapid
immunoassay
allinon
devic
base
immunochromatograph
method
previous
describ
devic
use
studi
schemat
depict
fig
rict
design
qualit
analysi
detect
nucleocapsid
protein
sarscov
basi
posit
neg
judgment
three
pad
fix
onto
sheet
nitrocellulos
membran
mm
mm
mm
w
l
respect
use
liquid
absorpt
sampl
applic
solut
develop
millipor
corp
cork
ireland
assembl
assay
devic
three
pad
place
entir
membran
cassett
mold
plastic
cover
make
allinon
devic
pad
membran
sheet
pretreat
follow
pad
solut
contain
antinag
sarscov
antibodi
conjug
alp
mm
bistri
buffer
ph
nacl
bsa
triton
absorb
onto
pad
size
mm
mm
mm
w
l
made
porou
matrix
pad
subsequ
dri
air
blow
addit
triton
essenti
avoid
interfer
immuno
andor
enzym
reaction
sampl
pad
bcip
ml
use
alp
substrat
absorb
onto
pad
dri
antialp
antibodi
antinag
sarscov
antibodi
immobil
r
posit
membran
sheet
detect
zone
r
indic
refer
test
line
respect
ml
diethanol
amin
buffer
ph
contain
mm
mgcl
use
develop
solut
ad
reservoir
seal
aluminum
film
assay
procedur
rict
perform
follow
ml
sampl
contain
either
recombin
nag
nativ
sarscov
antigen
drop
onto
sampl
applic
pad
develop
solut
reservoir
ruptur
press
finger
devic
incub
room
temperatur
min
sampl
applic
blue
line
observ
nake
eye
posit
judg
posit
band
observ
min
result
judg
neg
addit
line
posit
blue
line
appear
r
posit
use
index
valid
test
perform
viral
sampl
assay
studi
prepar
supernat
vero
cell
inocul
sarscov
patient
origin
viral
suspens
contain
tcid
ml
sarscov
dilut
accord
test
requir
tri
buffer
contain
nacl
bsa
unless
otherwis
state
nonidet
buffer
also
use
dilut
serum
nsp
necessari
prevent
sarscov
infect
assay
procedur
ad
sampl
buffer
inactiv
sarscov
ml
sampl
use
rict
assay
measur
analyt
sensit
rict
assay
nativ
sarscov
carri
use
sampl
prepar
serial
dilut
viral
cultur
contain
tcid
ml
sarscov
moab
pair
system
tcid
ml
pair
system
obtain
precis
limit
detect
test
perform
nine
dilut
dilut
posit
sampl
solut
antigen
level
tcid
ml
pair
system
tcid
ml
pair
system
measur
analyt
sensit
recombin
nag
use
sampl
serial
dilut
solut
contain
recombin
nag
ngml
highest
respect
dilut
sarscov
prepar
tcid
ml
recombin
nag
result
posit
judgment
defin
limit
analyt
sensit
present
studi
rict
specif
reproduc
analys
test
perform
use
pair
system
rict
specif
analysi
differ
human
sera
normal
human
sera
sera
pregnant
women
rheumatoid
arthriti
patient
well
human
nsp
includ
patient
infect
influenza
viru
test
collect
nsp
insert
tube
subject
nostril
parallel
palat
aspir
nasopharyng
secret
dispens
ml
steril
salin
ph
specimen
kept
steril
vial
use
experi
prepar
posit
serum
respiratori
aspir
mimic
patient
sampl
ad
ml
sarscov
suspens
tcid
ml
ml
human
serum
nsp
sampl
prepar
fold
dilut
stock
suspens
tcid
ml
use
normal
serum
nsp
subject
rict
assay
lowest
concentr
sarscov
tcid
ml
fold
dilut
sampl
coxsacki
viru
type
parainfluenza
viru
type
adenoviru
type
mump
viru
rubella
viru
measl
viru
respiratori
syncyti
viru
purchas
manufactur
denkaseiken
tokyo
japan
sampl
treat
uv
irradi
andor
bpropionlacton
manufactur
recombin
nucleocapsid
protein
sarscov
obtain
mostli
solubl
protein
highli
express
e
coli
system
fig
express
protein
purifi
subject
wb
analysi
major
band
molecular
mass
kda
observ
coomassi
brilliant
blue
stain
gel
sdspage
also
wb
use
mous
peptid
serum
fig
lane
moab
produc
immun
protein
recombin
nag
synthet
peptid
mice
six
moab
screen
abil
bind
recombin
nag
immobil
well
titrat
curv
shown
fig
four
moab
gave
concentr
ngml
maximum
absorb
rel
high
appar
affin
correspond
valu
ngml
indic
nearli
three
time
less
affin
compar
antibodi
moab
compar
bind
recombin
nag
competit
elisa
assay
typic
exampl
shown
tabl
ie
absorb
nm
alplabel
significantli
reduc
presenc
free
competitor
small
chang
absorb
occur
presenc
moab
base
competit
method
describ
moab
appear
bind
differ
epitop
appear
bind
epitop
recombin
nag
data
shown
confirm
immunoreact
nativ
antigen
sarscov
six
moab
subject
wb
compar
recombin
nag
use
recombin
nag
found
moab
reactiv
protein
molecular
mass
kda
fig
nativ
sarscov
use
band
pattern
similar
recombin
protein
observ
fig
detect
band
observ
mous
moab
relat
sarscov
appli
lane
fig
b
preliminari
experi
carri
evalu
moab
sandwich
format
elisa
assay
possibl
pair
combin
elisa
assay
use
moab
perform
four
pair
moab
pair
first
second
antibodi
solidphas
alp
label
respect
success
linear
dose
depend
obtain
recombin
nag
ng
ml
curv
j
k
fig
qualit
similar
result
obtain
sarscov
tcid
ml
data
shown
detect
limit
elisa
ngml
recombin
nag
tcid
ml
nativ
nag
sarscov
basi
elisa
result
evalu
five
moab
use
optim
condit
sandwichformat
rict
rict
develop
qualit
assay
method
detect
nag
sarscov
appear
blue
line
posit
devic
min
sampl
applic
judg
posit
possibl
pair
combin
among
moab
test
four
set
moab
pair
first
moab
immobil
second
label
antibodi
select
use
sarscov
possibl
candid
rict
term
detect
nag
serial
dilut
sampl
tabl
tabl
show
analyt
sensit
four
moab
pair
system
highest
analyt
sensit
obtain
use
pgml
recombin
nag
tcid
ml
nativ
antigen
sarscov
figur
show
test
result
sensit
detect
rict
system
use
solidphas
alp
label
respect
prior
analysi
test
sampl
contain
sarscov
heattreat
dilut
buffer
contain
describ
materi
method
intens
blue
line
observ
posit
gradual
weaken
consecut
dilut
appli
sampl
could
detect
dilut
tcid
ml
fig
lane
howev
line
could
observ
dilut
tcid
ml
min
fig
lane
probe
limit
analyt
sensit
test
nine
dilut
highest
dilut
posit
judgment
equival
concentr
tcid
ml
dilut
tcid
ml
remain
neg
thu
took
valu
tcid
ml
limit
analyt
sensit
also
perform
rict
use
sampl
absenc
without
heat
treatment
obtain
similar
result
data
shown
rict
specif
reproduc
analys
test
perform
use
pair
system
posit
control
prepar
mimick
serum
nsp
sar
patient
contain
cultur
sarscov
result
posit
sampl
tcid
ml
howev
result
use
tcid
ml
neg
specif
rict
assay
normal
sera
rheumatoid
arthriti
pregnanc
sera
sera
nsp
tabl
label
alp
use
detect
recombin
nag
immobil
well
free
moab
use
competitor
ad
togeth
alplabel
moab
well
describ
materi
method
absorb
measur
nm
indic
moab
antibodi
estradiol
use
control
percentag
indic
use
control
absorb
nsp
result
influenzainfect
sampl
influenza
virus
type
b
thu
result
influenza
sampl
also
show
crossreact
sarscov
occur
furthermor
infecti
virus
respiratori
tract
coxsacki
viru
type
parainfluenza
viru
type
adenoviru
type
mump
viru
rubella
viru
measl
viru
respiratori
syncyti
viru
test
rict
none
sampl
gave
posit
result
evalu
reproduc
rict
use
five
differ
sampl
fold
dilut
origin
viral
suspens
demonstr
rict
allinon
devic
use
mous
moab
immobil
antibodi
enzym
label
use
detect
nag
sarscov
although
could
confirm
sensit
rict
due
lack
avail
human
sar
patient
sampl
result
posit
sampl
tcid
ml
sarscov
use
mimick
serum
nsp
sar
patient
contain
cultur
sarscov
posit
control
specif
rict
assay
sera
nsp
tabl
howev
crossreact
use
human
coronaviru
remain
confirm
analyt
sensit
rict
recombin
nativ
nag
sarscov
tabl
ratio
tcid
concentr
recombin
nag
less
consist
except
pair
system
result
less
sensit
nativ
sarscov
compar
recombin
nag
result
may
indic
chang
reactiv
occur
nativ
nag
srascov
due
immobil
membran
devic
despit
lower
appar
affin
fig
show
highli
sensit
result
use
label
antibodi
indic
bind
strongli
freeform
nag
immobil
nag
high
analyt
sensit
rict
use
pair
obtain
pgml
recombin
nag
tcid
ml
sarscov
tabl
eia
method
employ
analyt
sensit
rict
less
consist
lower
limit
detect
elisa
fig
analyt
sensit
similar
obtain
elisa
use
mixtur
moab
captur
nag
polyclon
antibodi
detector
result
suggest
presenc
triton
enabl
detect
nag
sarscov
condit
would
otherwis
possibl
triton
may
caus
destruct
sarscov
particl
viral
nantigen
may
thu
becom
detect
rict
effect
triton
transmiss
gastroenter
viru
member
coronaviru
famili
address
confirm
spheric
core
structur
viru
maintain
treatment
triton
react
moab
specif
nag
transmiss
gastroenter
viru
given
result
obtain
elisa
rict
confirm
detect
nag
sarscov
use
heattreat
sarscov
sampl
without
triton
elisa
sampl
without
heat
treatment
absenc
rict
conclud
treatment
either
heat
triton
allow
nag
sarscov
detect
molecular
mass
nag
kda
calcul
amino
acid
sequenc
consist
kda
observ
sdspage
wb
fig
like
viral
antigen
reactiv
moab
nucleocapsid
protein
also
immunoreact
recombin
nag
appear
qualit
similar
nativ
nag
regardless
protein
configur
use
denatur
intact
moab
react
recombin
nag
also
nativ
nag
fig
indic
moab
abl
recogn
epitop
nag
independ
higherord
protein
configur
construct
dna
base
urbani
strain
express
nag
e
coli
system
genom
nag
sequenc
sarscov
urbani
twh
shanghai
etc
report
genbank
chang
nucleic
acid
sequenc
found
howev
put
amino
acid
sequenc
nag
strain
except
strain
one
two
amino
acid
chang
due
nucleic
acid
mutat
ie
frankfurt
fra
amino
acid
chang
thr
ile
amino
acid
chang
asn
tyr
amino
acid
chang
gli
cy
shanghai
ly
amino
acid
chang
val
ala
thr
ala
among
four
mutat
strain
express
recombin
nag
frankfurt
shanghai
ly
strain
e
coli
system
detect
rict
preliminari
experi
studi
need
confirm
reactiv
nag
variant
rict
method
describ
conclus
although
rict
analyt
sensit
may
lower
pcr
compar
elisa
method
nonetheless
use
detect
nag
addit
assay
involv
simpl
manipul
short
detect
time
crossreact
respiratoryrel
virus
describ
studi
thu
believ
rict
equal
use
method
pointofcar
test
diagnos
treat
sarssuspect
patient
